Vaccine Adjuvants Market Analysis, Major Vendors Analysis, Revenue, Segments and Emerging Technologies 2027


Vaccine Adjuvants Market Overview

Government vaccination campaigns, the high prevalence of infectious and zoonotic diseases and a greater effect of long-term vaccination against progressive and current diseases are important drivers of the expansion of the vaccine adjuvants market. According to MRFR, the market is expected to benefit from a 10.1% CAGR by the end of the forecast period.

The development of business R&D investments and the increase in immunization needs drive the vaccine adjuvants market forward during the forecast period. Furthermore, the intensification of the use of synthetic and recombinant vaccines is expected to propel the vaccine adjuvants market during the forecast period. On the other hand, high adjuvant toxicity and high development costs for new vaccine adjuvants may hamper market expansion.

Get a free sample @

Segment analysis

the vaccine adjuvants market is categorized by type, method of administration, and end users in the segmentation analysis. It is subdivided into pathogenic components and particulate adjuvants according to their types. It is subdivided into four modes of administration: oral, intramuscular, subcutaneous and intradermal. It is differentiated according to end users: pediatric and adult.

Detailed regional analysis

The global vaccine adjuvants market is divided into four regions: Americas, Europe, Asia-Pacific, Middle East, and Africa. The Americas hold the largest market share due to favorable conditions for research and development and the common use of the vaccine to prevent non-communicable and communicable diseases. Europe is the second largest market for vaccine adjuvants, due to access to funds for R&D activities and constant action taken by government and NGOs for disease prevention measures. Due to the pervasiveness of communicable diseases, Asia-Pacific is the fastest growing region of the global market. With improvements in health care and increasing disease prevalence, India and China are expected to be the fastest growing markets.

Competitive analysis

The market is expected to witness an improvement in growth signals in the near future. The recovered market potential is expected to increase the progress of the world market. Critical policies developed by government agencies around the world are believed to play a powerful role in the global advancement of the market. The restructuring of fundamental market operations is expected to impact the market shortly. The upsurge in innovative technologies in the global supply chain is expected to generate opportunities during the forecast period. The stability of market output is expected to vary. Each manufacturer must make microeconomic decisions to ensure long-term growth and business continuity during the forecast period. The post-pandemic hypervigilance mindset aims to guide market decisions throughout the projected period. It is believed that the drastic changes of the COVID-19 pandemic in the global structure of financial intermediation will influence how companies acquire finance over the comparable period.

The main competitors in the vaccine adjuvants market are Vaxine Pty Ltd (Australia), MPV Technologies (USA), Aphios Corporation (USA), Viscogel AB (Sweden), Adjuvatis (France), CureVac AG (Germany) , CSL Limited (Australia), VaxLiant LLC. (United States), Agenus, Inc. (United States), Novavax, Inc. (United States), SEPPIC (France), Sigma-Aldrich Co. LLC. (India), Sergeant Adjuvants (US), SPI Pharma, Inc. (US), Avanti Polar Lipids, Inc. (US), Brenntag Biosector (Denmark), Invivogen (US) and OZ Biosciences (France).

Industry Updates:

Dec 2021 Researchers at MIT, the La Jolla Institute of Immunology and other institutions have developed a new nanoparticulate adjuvant that may be more effective than those already in use. In studies on mice, it dramatically improved antibody production after vaccination against HIV, diphtheria, and influenza. Although the concept of using adjuvants to increase vaccine effectiveness has been around for decades, there are only a few adjuvants in FDA-approved vaccines.

Read the full report @

About Market Research Future:

At Market Research Future (MRFR), we enable our clients to disentangle the complexity of various industries through our Cooked Research Reports (CRR), Semi-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous Feed Research (CFR) and market research and consulting Services.

The ultimate goal of the MRFR team is to provide top quality market research and intelligence services to our clients. Our market research by components, applications, logistics and market players for global, regional and national market segments, enables our customers to see more, know more and do more, which helps to answer all of their most important questions.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5th Floor, New York, New York 10013,

united states of america

+1 646 845 9312

Email: [email protected]


About Author

Comments are closed.